We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+10.43%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.38B
AUM Growth
+$356M
Cap. Flow
-$95.3M
Cap. Flow %
-1.77%
Top 10 Hldgs %
22.08%
Holding
225
New
6
Increased
74
Reduced
113
Closed
13

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$41.5M
2
SLB icon
SLB Ltd
SLB
+$19.4M
3
GSK icon
GSK
GSK
+$15.1M
4
EOG icon
EOG Resources
EOG
+$10.5M
5
APA icon
APA Corp
APA
+$9M

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$80.1M
2
CELG
Celgene Corp
CELG
+$72.6M
3
BWA icon
BorgWarner
BWA
+$26.4M
4
EXPE icon
Expedia Group
EXPE
+$26.1M
5
XRAY icon
Dentsply Sirona
XRAY
+$19.3M

Sector Composition

Rank Sector Weight
1 Financials 23.04%
2 Technology 14.53%
3 Industrials 13.46%
4 Healthcare 13.02%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BN icon
176
Brookfield
BN
$108B
$318K 0.01%
15,415
– –
DD icon
177
DuPont de Nemours
DD
$19.5B
$314K 0.01%
3,900
-504
-11% -$41.8K
MO icon
178
Altria Group
MO
$113B
$314K 0.01%
6,299
-1,792
-22% -$84.5K
TXN icon
179
Texas Instruments
TXN
$254B
$311K 0.01%
+2,424
New +$299K
LMT icon
180
Lockheed Martin
LMT
$135B
$304K 0.01%
781
+114
+17% +$43.7K
HUBB icon
181
Hubbell
HUBB
$26.8B
$303K 0.01%
2,050
– –
CTSH icon
182
Cognizant
CTSH
$25.6B
$298K 0.01%
4,800
-9
-0.2% -$556
TRV icon
183
Travelers Companies
TRV
$80.5B
$298K 0.01%
2,174
+70
+3% +$9.53K
PNC icon
184
PNC Financial Services
PNC
$101B
$292K 0.01%
1,829
-100
-5% -$15K
HSY icon
185
Hershey
HSY
$36.8B
$291K 0.01%
1,981
-50
-2% -$7.41K
MMP
186
DELISTED
Magellan Midstream Partners, L.P.
MMP
$286K 0.01%
4,550
-1,000
-18% -$62.3K
BAX icon
187
Baxter International
BAX
$14B
$284K 0.01%
3,400
-30
-0.9% -$2.48K
GILD icon
188
Gilead Sciences
GILD
$162B
$272K 0.01%
4,193
-412
-9% -$26.8K
DOW icon
189
Dow Inc
DOW
$21.9B
$270K 0.01%
4,933
-532
-10% -$27.5K
RDS.A
190
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$265K ﹤0.01%
4,497
+499
+12% +$29.1K
BLK icon
191
Blackrock
BLK
$175B
$258K ﹤0.01%
513
+25
+5% +$11.9K
TJX icon
192
TJX Companies
TJX
$179B
$244K ﹤0.01%
3,990
+204
+5% +$12.1K
BF.B icon
193
Brown-Forman Class B
BF.B
$13B
$228K ﹤0.01%
3,375
– –
CSX icon
194
CSX Corp
CSX
$93.9B
$225K ﹤0.01%
+9,309
New +$220K
NEE icon
195
NextEra Energy
NEE
$176B
$218K ﹤0.01%
3,608
-200
-5% -$11.7K
PGR icon
196
Progressive
PGR
$125B
$217K ﹤0.01%
3,003
-160
-5% -$11.5K
BKNG icon
197
Booking.com
BKNG
$156B
$212K ﹤0.01%
2,575
-250
-9% -$19.6K
AEP icon
198
American Electric Power
AEP
$68.2B
$211K ﹤0.01%
2,228
– –
NFLX icon
199
Netflix
NFLX
$307B
$206K ﹤0.01%
6,370
-3,510
-36% -$104K
HCA icon
200
HCA Healthcare
HCA
$88.5B
$204K ﹤0.01%
+1,380
New +$185K
5 6 7
8
9

Similar funds

BIM
Bridges Investment Management Omaha, Nebraska $7.38B AUM 15.39% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Douglas Lane & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Douglas Lane & Associates held 225 positions worth $5.38B, up 7.1% from $5.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Douglas Lane & Associates's Q4 2019 filing shows 6 new, 74 increased, 113 reduced and 13 closed positions. Its largest new stake was Elanco Animal Health: 120,472 shares worth $3.55M. The largest sale was People Inc, an estimated $80.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Douglas Lane & Associates's largest Q4 2019 buy was Elanco Animal Health: 120,472 shares worth $3.55M.
  • Douglas Lane & Associates added most to Bristol-Myers Squibb in Q4 2019, an estimated $41.5M increase.
  • Douglas Lane & Associates's biggest Q4 2019 reduction was People Inc, cutting an estimated $80.1M.
  • Douglas Lane & Associates fully exited Celgene Corp in Q4 2019, selling an estimated $72.6M.
  • Douglas Lane & Associates's ten largest holdings make up 22% of its $5.38B portfolio in Q4 2019.
  • Douglas Lane & Associates opened 6 new positions and closed 13 in Q4 2019.
  • Douglas Lane & Associates's portfolio value rose 7.1% quarter-over-quarter to $5.38B.

Based on Douglas Lane & Associates's 13F filing for Q4 2019, filed 27 Jan 2020.